http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2266147-C1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
filingDate 2004-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_088a258b6b7b82f1a896d488b3ee7deb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb4a92191491d0cae7acc2d359a161c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d05ae3bf82f0045b04e3ac3278a2941
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b542fb4c7aff4b62a6cee5283dd4389a
publicationDate 2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2266147-C1
titleOfInvention Method for treating equine aseptic tendovaginitis
abstract FIELD: veterinary science. n SUBSTANCE: one should carry out daily laser impact upon affected area and additionally once /2 d apply a compress of medicinal preparation containing the suspension of 25%-hydrocortisone, phenylbutazone, "Arnica" liniment and dimethylsulfoxide solution at the following ratio of components, weight%: 25%-hydrocortisone suspension 1.0; phenylbutazone suspension 0.65; "Arnica" liniment suspension 50.0, dimethylsulfoxide solution - the rest. Moreover, expenses of medicinal remedy should be fulfilled at 100 ml/200 sq. cm, as for laser impact, it should be carried out with low-intensity infrared laser radiation at impulses frequency being 512 Hz, power of 16 W and exposure time being 6 min. The innovation suggested enables to remove post-traumatic edema and inflammation, stimulates regenerative processes in inflammatory focus at the shortest terms. n EFFECT: higher efficiency of therapy. n 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2702757-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2576031-C1
priorityDate 2004-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID436207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID436207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4781

Total number of triples: 29.